Replies to post #2617 on Regenicin Inc (RGIN)

[nidan7500]

Changes to FDA trials protocols are certainly a factor here. Required resources to deal w/FDA must be a factor in any planning. Recent sign of trading life are positive, IMO. Note, all BIO are going through the same thing w/FDA new rules.